content

Introduction of Anti-Evolocumab Antibodies From Bio-Rad

A group of type 1 antibodies recently made available by Bio-Rad Laboratories are intended to prevent the drug evolcumab from attaching to its target,...

For $1.1 Billion, Novo Nordisk To Buy Forma Therapeutics

On September 1, 2022, Novo Nordisk and Forma Therapeutics revealed that Novo Nordisk would buy Forma Therapeutics for for $1.1 billion. With the purchase...

Merck Assesses 5 Years of Keytruda Lung Cancer Research

By demonstrating a massive survival benefit, Keytruda's Keynote-189 study precipitated a turning point in the development of lung cancer medications. Merck & Co. is...

Modus Therapeutics Enrols First Patient To Explore Sevuparin

The treatment for paediatric patients with severe malaria is being evaluated through research. The first patient has been enrolled in the SEVUSMART study, according to...

Leg Ulcers: How Do They Form And How To Treat Them

Leg ulcers are common and often painful wounds that can form on the leg. They can be caused by a number of factors, including...

ChargePoint Technology Acquires PuroVaso

ChargePoint Technology Group, the powder and liquid transfer specialist and a portfolio company of Arcline Investment Management, has announced the acquisition of PuroVaso, a...

First Drug For Acid Sphingomyelinase Loss Approved By FDA

For intravenous infusion in paediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD), a rare genetic disorder that results in early death, the U.S....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read